Curriculum-Based Online and Live Activities

 


Course Director
Edward J. Fox, MD, PhD
MS Clinic of Central Texas
Central Texas Neurology Consultants
Round Rock, Texas


Curriculum Description

Clinical and scientific research in multiple sclerosis (MS) continues to progress at a rapid rate; a number of oral disease-modifying therapies and monoclonal antibodies with novel mechanisms of action have been approved since 2010. In addition, updates to the diagnostic criteria and clinical course descriptions (phenotypes) for this disease have emerged in parallel with these aforementioned treatment advances. Since family physicians and general practitioners often play a central role in the initial assessment, recognition, and subsequent referral to secondary care for formal diagnosis and treatment of patients with suspected MS, as well as contribute to the overall management of the health of these patients, it is imperative for physicians to stay current with the latest advances in MS care.

Through this curriculum, we hope to provide primary care clinicians with the necessary knowledge and skills to readily recognize and initially assess patients with suspected MS; address potential adverse effects that patients with this disease might experience during treatment with disease-modifying therapies; and refer patients with MS to secondary care clinicians and coordinate the management of their care in a timely manner. To learn more, join Dr. Edward Fox for this engaging educational activity, or join us for one of our planned AAFP chapter meetings.

Target Audience

This activity has been designed to meet the educational needs of family practitioners, general practitioners, and other clinicians involved in the management of patients with multiple sclerosis.